These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35280834)

  • 1. Antioxidant effects of astaxanthin and metformin combined therapy in type 2 diabetes mellitus patients: a randomized double-blind controlled clinical trial.
    Rad NR; Movahedian A; Feizi A; Aminorroaya A; Aarabi MH
    Res Pharm Sci; 2022 Apr; 17(2):219-230. PubMed ID: 35280834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: a randomized controlled trial.
    Panahi Y; Khalili N; Sahebi E; Namazi S; Karimian MS; Majeed M; Sahebkar A
    Inflammopharmacology; 2017 Feb; 25(1):25-31. PubMed ID: 27928704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of taurine supplementation on oxidative stress indices and inflammation biomarkers in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
    Maleki V; Mahdavi R; Hajizadeh-Sharafabad F; Alizadeh M
    Diabetol Metab Syndr; 2020; 12():9. PubMed ID: 32015761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Protective Effect of Astaxanthin on Cognitive Function via Inhibition of Oxidative Stress and Inflammation in the Brains of Chronic T2DM Rats.
    Feng Y; Chu A; Luo Q; Wu M; Shi X; Chen Y
    Front Pharmacol; 2018; 9():748. PubMed ID: 30042685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astaxanthin ameliorates inflammation, oxidative stress, and reproductive outcomes in endometriosis patients undergoing assisted reproduction: A randomized, triple-blind placebo-controlled clinical trial.
    Rostami S; Alyasin A; Saedi M; Nekoonam S; Khodarahmian M; Moeini A; Amidi F
    Front Endocrinol (Lausanne); 2023; 14():1144323. PubMed ID: 37020589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress and nitrate/nitrite (NOx) status following citrulline supplementation in type 2 diabetes: a randomised, double-blind, placebo-controlled trial.
    Azizi S; Ebrahimi-Mameghani M; Mobasseri M; Karamzad N; Mahdavi R
    J Hum Nutr Diet; 2021 Feb; 34(1):64-72. PubMed ID: 32683790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial of astaxanthin impacts on antioxidant status and assisted reproductive technology outcomes in women with polycystic ovarian syndrome.
    Gharaei R; Alyasin A; Mahdavinezhad F; Samadian E; Ashrafnezhad Z; Amidi F
    J Assist Reprod Genet; 2022 Apr; 39(4):995-1008. PubMed ID: 35237893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Silybum marianum (L.) Gaertn. (silymarin) extract supplementation on antioxidant status and hs-CRP in patients with type 2 diabetes mellitus: a randomized, triple-blind, placebo-controlled clinical trial.
    Ebrahimpour Koujan S; Gargari BP; Mobasseri M; Valizadeh H; Asghari-Jafarabadi M
    Phytomedicine; 2015 Feb; 22(2):290-6. PubMed ID: 25765835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of NRF2 gene expression and antioxidant status in patients with type 2 diabetes mellitus after supplementation with omega-3 polyunsaturated fatty acids: A double-blind randomised placebo-controlled clinical trial.
    Golpour P; Nourbakhsh M; Mazaherioun M; Janani L; Nourbakhsh M; Yaghmaei P
    Diabetes Res Clin Pract; 2020 Apr; 162():108120. PubMed ID: 32194222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antioxidant and anti-inflammatory effects of astaxanthin supplementation on the expression of miR-146a and miR-126 in patients with type 2 diabetes mellitus: A randomised, double-blind, placebo-controlled clinical trial.
    Shokri-Mashhadi N; Tahmasebi M; Mohammadi-Asl J; Zakerkish M; Mohammadshahi M
    Int J Clin Pract; 2021 May; 75(5):e14022. PubMed ID: 33445213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligopin® Supplementation Mitigates Oxidative Stress in Postmenopausal Women with Osteopenia: A Randomized, Double-blind, Placebo-Controlled Trial.
    Majidi Z; Ansari M; Maghbooli Z; Ghasemi A; Ebrahimi SSS; Hossein-Nezhad A; Emamgholipour S
    Phytomedicine; 2021 Jan; 81():153417. PubMed ID: 33250314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impacts of Synbiotic Supplementation on Periodontal Indices and Biomarkers of Oxidative Stress in Type 2 Diabetes Mellitus Patients with Chronic Periodontitis Under Non-Surgical Periodontal Therapy. A Double-Blind, Placebo-Controlled Trial.
    Bazyar H; Maghsoumi-Norouzabad L; Yarahmadi M; Gholinezhad H; Moradi L; Salehi P; Haghighi-Zadeh MH; Zare Javid A
    Diabetes Metab Syndr Obes; 2020; 13():19-29. PubMed ID: 32021348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of JYTK on Antioxidant Status and Inflammation in Patients With Type 2 Diabetes: A Randomized Double-Blind Clinical Trial.
    Hu Y; Zhou X; Guo DH; Liu P
    Int J Endocrinol Metab; 2016 Jan; 14(1):e34400. PubMed ID: 27279835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant and Anti-Inflammatory Properties of Melatonin in Patients with Type 2 Diabetes Mellitus with Periodontal Disease Under Non-Surgical Periodontal Therapy: A Double-Blind, Placebo-Controlled Trial.
    Zare Javid A; Hosseini SA; Gholinezhad H; Moradi L; Haghighi-Zadeh MH; Bazyar H
    Diabetes Metab Syndr Obes; 2020; 13():753-761. PubMed ID: 32256092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global Oxidative Status Is Linked to Calcific Aortic Stenosis: The Differences Due to Diabetes Mellitus and the Effects of Metformin.
    Corbacho-Alonso N; Rodríguez-Sánchez E; Sastre-Oliva T; Mercado-García E; Perales-Sánchez I; Juarez-Alia C; López-Almodovar LF; Padial LR; Tejerina T; Mourino-Alvarez L; Ruiz-Hurtado G; Barderas MG
    Antioxidants (Basel); 2023 Apr; 12(5):. PubMed ID: 37237890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of oral butyrate and inulin supplementation on inflammation-induced pyroptosis pathway in type 2 diabetes: A randomized, double-blind, placebo-controlled trial.
    Roshanravan N; Alamdari NM; Jafarabadi MA; Mohammadi A; Shabestari BR; Nasirzadeh N; Asghari S; Mansoori B; Akbarzadeh M; Ghavami A; Ghaffari S; Ostadrahimi A
    Cytokine; 2020 Jul; 131():155101. PubMed ID: 32315958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Pharmacologic Dose of Resveratrol Supplementation on Oxidative/Antioxidative Status Biomarkers in Nonalcoholic Fatty Liver Disease Patients: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Asghari S; Rafraf M; Farzin L; Asghari-Jafarabadi M; Ghavami SM; Somi MH
    Adv Pharm Bull; 2018 Jun; 8(2):307-317. PubMed ID: 30023333
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of coenzyme Q
    Zarei P; Rezvanfar MR; Ansarihadipour H; Delavar M; Abdollahi M; Khosrowbeygi A
    J Res Med Sci; 2018; 23():91. PubMed ID: 30505329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astaxanthin and omega-3 fatty acids individually and in combination protect against oxidative stress via the Nrf2-ARE pathway.
    Saw CL; Yang AY; Guo Y; Kong AN
    Food Chem Toxicol; 2013 Dec; 62():869-75. PubMed ID: 24157545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial.
    Seyyedebrahimi S; Khodabandehloo H; Nasli Esfahani E; Meshkani R
    Acta Diabetol; 2018 Apr; 55(4):341-353. PubMed ID: 29357033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.